Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (5945)	11/16/1998 7:26:00 AM
From: Linda Kaplan	Read Replies (2) \| Respond to of 7041

There had to be some hype to bring the stock up over 21. So I guess that was the hype. Earnings. In how many countries has Vasomax been approved, so in how many countries can it have earnings? I thought just Mexico, but did I miss some countries? My impression is that Mexico sales are poor, so could these earnings have come from that? Generally the marketplace doesn't place stock in one shot settlements, in terms of that improving the stock price significantly and over long term. So the fact that ZONA got some settlements from Schering shouldn't do much for the stock price over the long run. I'll be eager to see those earnings and I'd expect the stock price to continue dropping. Linda